Nukkleus Inc (NASDAQ: NUKK) soared over 40% this morning after announcing a strategic joint venture with “Mandragola” aimed at modernising aviation infrastructure across Europe and Israel.
The deal broadens NUKK’s presence in the fast-growing aircraft maintenance, repair, and overhaul (MRO) market, which was valued at about $110 billion in 2024.
Nukkleus stock has been thoroughly disappointing for investors this year. Despite today’s rally, it’s down more than 80% versus its year-to-date high in late January.
Why Mandragola deal is significant for Nukkleus stock
Teaming up with the Israeli company could prove meaningfully positive for NUKK shares because it positions them to benefit from Europe’s evolving defense landscape.
With geopolitical tensions rising in Eastern Europe, particularly due to the Russia-Ukraine conflict, demand for resilient aviation infrastructure is expected to climb.
In fact, the global MRO market is broadly expected to surpass $125 billion valuation over the next ten years, offering ample runway for Nukkleus to scale operations and tap into long-term defence spending cycles.
Note that the Mandragola joint venture will establish advanced aviation hubs in Baltics and Israel, including a NATO-compliant logistics facility in Riga – supporting both military and civil aviation needs.
Recent BladeRanger deal also bode well for NUKK shares
Nukkleus shares are rallying this morning also because the Nasdaq-listed firm signed an exclusive US distribution agreement with another Israeli firm, BladeRanger, on August 26th.
According to the company’s recent press release, it has secured exclusive rights to commercialise BLRN’s surveillance and tactical drone systems across American defence and homeland security markets.
The three-year agreement won Nukkleus exposure to another fast-growing segment within defence technology – “drone payload” – expected to be worth over $33 billion by the end of this decade.
Nukkleus chief executive Menny Shalom called the move “transformative”, adding it aligns with the firm’s broader goal of building a high-tech ecosystem of A&D solutions.
Investors should note that the BladeRanger transaction includes performance-based incentives and minimum purchase commitments as well – signalling a serious push toward revenue generation.
Why Nukkleus shares remain unattractive in 2025
Despite the aforementioned flurry of strategic announcements, Nukkleus stock remains a high-risk investment for the second half of 2025.
Why? NUKK shares do not currently receive coverage from Wall Street analysts, leaving investors with limited visibility into its financial health and growth trajectory.
Moreover, the company based out of Jersey City, NJ, is yet to report consistent profitability, with recent filings showing negative net margins and shareholder dilution.
While the Mandragola and BladeRanger deals offer compelling narratives, they are still early-stage initiatives with execution risk.
Plus, the absence of institutional coverage and unstable financials make it difficult to assess valuation or forecast future performance.
Therefore, NUKK stock may be riding a wave of momentum – but investors should keep one eye on the fundamentals.
The post Nukkleus stock soars on Mandragola deal: sell NUKK before it retreats appeared first on Invezz
